TISSIUM
http://tissium.com
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From TISSIUM
Investor Eye: Sofinnova Speaks On Deal Execution, Managing Expertise And what’s In Store For The Future
Times may look bleak for medtech investment. Public markets are down and VC is shyer than ever about spending money. Medtech Insight spoke to Antoine Papiernik of Sofinnova Partners to learn more about the path forward.
Tissium Hopes Its Programmable Polymer Will Be A Gamechanger For Nerve Repair
The company has developed a highly-customizable polymer that can repair tissue, negating the need for stitches and staples, for use in multiple applications.
Company Information
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice